Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

13 déc. 2025 13h07 HE | Source: Hagens Berman Sobol Shapiro LLP

MLTX 2-DAY DEADLINE ALERT: MoonLake (MLTX) Class Action Lawsuit – Hagens Berman Scrutinizing Nanobody Superiority Claims After 90% Plunge; December Lead Plaintiff Deadline Looms

Investors who lost money in MLTX after its stock plunged 90% due to allegedly misleading financial statements are urged to contact Hagens Berman.
11 déc. 2025 12h53 HE | Source: Hagens Berman Sobol Shapiro LLP

MLTX 4-DAY DEADLINE ALERT: MoonLake (MLTX) Class Action Lawsuit – Hagens Berman Scrutinizing Nanobody Superiority Claims After 90% Plunge; December Lead Plaintiff Deadline Looms

Investors who lost money in MoonLake after its stock plunged 90% due to allegedly misleading financial statements are urged to contact Hagens Berman.
08 déc. 2025 10h45 HE | Source: Berger Montague

DEADLINE APPROACHING: Berger Montague Advises MoonLake Immunotherapeutics (NASDAQ: MLTX) Investors to Inquire About a Securities Fraud Class Action by December 15, 2025

PHILADELPHIA, Dec. 08, 2025 (GLOBE NEWSWIRE) -- National plaintiffs’ law firm Berger Montague PC announces a class action lawsuit against MoonLake Immunotherapeutics (NASDAQ: MLTX) (“MoonLake” or...
08 déc. 2025 10h15 HE | Source: Bernstein Liebhard LLP

MOONLAKE IMMUNOTHERAPEUTICS (NASDAQ: MLTX) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds MoonLake Immunotherapeutics Investors of Upcoming Deadline

MoonLake Immunotherapeutics Shareholder Lawsuit Filed - Contact Bernstein Liebhard For More Information
05 déc. 2025 10h30 HE | Source: Bernstein Liebhard LLP

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against MoonLake Immunotherapeutics (NASDAQ: MLTX)

MoonLake Immunotherapeutics Shareholder Lawsuit Filed - Contact Bernstein Liebhard For More Information
03 déc. 2025 12h15 HE | Source: Bernstein Liebhard LLP

MOONLAKE IMMUNOTHERAPEUTICS (NASDAQ: MLTX) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds MoonLake Immunotherapeutics Investors of Upcoming Deadline

MoonLake Immunotherapeutics (MLTX) Shareholder Lawsuit Filed - Contact Bernstein Liebhard For More Information
01 déc. 2025 08h45 HE | Source: Bernstein Liebhard LLP

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against MoonLake Immunotherapeutics (NASDAQ: MLTX)

MoonLake Immunotherapeutics (MLTX) Shareholder Lawsuit Filed - Contact Bernstein Liebhard For More Information
24 nov. 2025 08h41 HE | Source: Bernstein Liebhard LLP

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against MoonLake Immunotherapeutics (NASDAQ: MLTX)

MoonLake Immunotherapeutics (MLTX) Shareholder Lawsuit Filed - Contact Bernstein Liebhard For More Information
17 nov. 2025 09h00 HE | Source: Bernstein Liebhard LLP

MOONLAKE IMMUNOTHERAPEUTICS (NASDAQ: MLTX) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds MoonLake Immunotherapeutics Investors of Upcoming Deadline

MoonLake Immunotherapeutics (MLTX) Shareholder Lawsuit Filed - Contact Bernstein Liebhard For More Information
14 nov. 2025 11h17 HE | Source: Bernstein Liebhard LLP

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Baxter International Inc. (NYSE: BAX)

MoonLake Immunotherapeutics (MLTX) Shareholder Lawsuit Filed - Contact Bernstein Liebhard For More Information